MDM2 and glioblastoma: RG7112 was designed to target MDM2 in p53-binding pocket (Vu et al., 2013) and restored p53 activity inducing robust p21 expression and apoptosis in p53 wild-type glioblastomas cell (Verreault et al., 2016).